Browse by author
Lookup NU author(s): Professor Heinz Grunze
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Anticonvulsant drugs are widely used in psychiatric indications. These include mainly alcohol and benzodiazepine withdrawal syndromes, panic and anxiety disorders, dementia, schizophrenia, affective disorders, bipolar affective disorders in particular, and, to some extent, personality disorders. A further area in which neurology and psychiatry overlap is pain conditions, in which some anticonvulsants, and also typical psychiatric medications such as antidepressants, are helpful. From the beginning of their psychiatric use, anticonvulsants have also been used to ameliorate specific symptoms of psychiatric disorders independently of their causality and underlying illness, eg, aggression, and, more recently, cognitive impairment, as seen in affective disorders and schizophrenia. With new anticonvulsants currently under development, it is likely that their use in psychiatry will further increase, and that psychiatrists need to learn about their differential efficacy and safety profiles to the same extent as do neurologists. © 2008, LLS SAS.
Author(s): Grunze HCR
Publication type: Review
Publication status: Published
Journal: Dialogues in Clinical Neuroscience
Year: 2008
Volume: 10
Issue: 1
Pages: 77-89
Print publication date: 01/01/2008
ISSN (print): 1294-8322
ISSN (electronic):
PubMed id: 18472486
